Auteurs
Analysis
Canada
Racine
Analysis
Canada
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « Hui K. Gan »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hui Guo < Hui K. Gan < Hui Luo  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000E37 (2013) Julien Péron [Canada] ; Denis Maillet ; Hui K. Gan ; Eric X. Chen ; Benoit YouAdherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review.
000F64 (2013) Julien Peron [France] ; Denis Maillet [France] ; Hui K. Gan [Australie] ; Eric X. Chen [Canada] ; Benoit You [France]Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review
001007 (2012) Christophe Le Tourneau [France] ; Hui K. Gan [Australie] ; Albiruni R. A. Razak [Canada] ; Xavier Paoletti [France]Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents
001107 (2012) Julien Peron [France] ; Gregory R. Pond [Canada] ; Hui K. Gan [Australie] ; Eric X. Chen [Canada] ; Roula Almufti [France] ; Denis Maillet [France] ; Benoit You [France]Quality of Reporting of Modern Randomized Controlled Trials in Medical Oncology: A Systematic Review
001156 (2012) Benoit You [Canada, France] ; Hui K. Gan [Canada, Australie] ; Gregory Pond [Canada] ; Eric X. Chen [Canada]Consistency in the Analysis and Reporting of Primary End Points in Oncology Randomized Controlled Trials From Registration to Publication: A Systematic Review
001172 (2012) Hui K. Gan [Australie] ; Benoit You [Canada, France] ; Gregory R. Pond [Canada] ; Eric X. Chen [Canada]Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer
001323 (2011) Christophe Le Tourneau [France] ; Albiruni R. A. Razak [Canada] ; Christine Levy [France] ; Valentin Calugaru [France] ; Olivier Galatoire [France] ; Remi Dendale [France] ; Laurence Desjardins [France] ; Hui K. Gan [Australie]Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland
001367 (2011) Christophe Le Tourneau [France] ; Albiruni R. A. Razak [Canada] ; Hui K. Gan [Australie] ; Simona Pop [France] ; Véronique Dieras [France] ; Patricia Tresca [France] ; Xavier Paoletti [France]Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: A review of the literature
001454 (2010) Christophe Le Tourneau [France, Niger] ; Albiruni R A. Razak [Canada] ; Christine Levy [France] ; Valentin Calugaru [France] ; Olivier Galatoire [France] ; Rémi Dendale [France] ; Laurence Desjardins [France] ; Hui K. Gan [Australie]Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland

List of associated KwdEn.i

Nombre de
documents		Descripteur
5Cancerology
5Malignant tumor
4Treatment
3Bibliographic review
3Cancer
3Chemotherapy
2Carcinoma
2Human
2Lacrimal gland
2Randomization
2Randomized controlled trial
2Toxicity
1Adenoid
1Adhesion
1Adjuvant
1Adjuvant chemotherapy
1Antineoplastic Agents (adverse effects)
1Antineoplastic agent
1Apoptosis
1Apoptosis proteins
1Cell carcinoma
1Cell lines
1Cisplatin
1Clin
1Clin cancer
1Clinical Trials, Phase III as Topic
1Clinical outcome
1Clinical trial
1Definition
1Dose
1Drug-Related Side Effects and Adverse Reactions
1Egfr
1Epidermal
1Epidermal growth factor receptor
1Epithelial
1Evidence-based medicine
1Extracellular
1Gland
1Growth factor
1Guideline Adherence (standards)
1Guideline Adherence (statistics & numerical data)
1Guidelines as Topic
1Her2
1Heterogeneity
1Humans
1Imatinib
1Imatinib mesylate
1Immunohistochemical study
1Inhibitor
1Institut curie
1Kinase
1Lacrimal
1Lacrimal gland adenoid
1Matrix
1Metastasis
1Metastatic
1Metastatic disease
1Mutation
1Neck cancer
1Neoadjuvant
1Neoadjuvant chemotherapy
1Neoplasms (drug therapy)
1Oncogene homologue
1Oncol
1Ophthalmol
1Ophthalmology
1Oral pathol
1Partial response
1Pathol
1Pathway
1Perineural
1Perineural invasion
1Phase I trial
1Phase III trial
1Postoperative radiotherapy
1Primary
1Prognostic
1Published document
1Quality
1Radiotherapy
1Randomized Controlled Trials as Topic (standards)
1Receptor
1Recommendation
1Recurrence
1Retrospective data
1Reversibility
1Salivary
1Salivary adenoid
1Salivary gland
1Salivary gland adenoid
1Salivary gland carcinoma
1Salivary gland carcinomas
1Salivary glands
1Secondary effect
1Solid tumors
1Systematic review
1Systemic therapy
1Targeted drug
1Targeted therapy
1Tumour

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Hui K. Gan" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Hui K. Gan" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Hui K. Gan
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024